foxo4-dri vs gdf-11

foxo4-dri vs gdf-11 Structural basis for potency differences between GDF8 and GDF11 | BMC Biology FOXO4-DRI alleviates age-related testosterone secretion

Name: foxo4-dri vs gdf-11 Structural basis for potency differences between GDF8 and GDF11 | BMC Biology FOXO4-DRI alleviates age-related testosterone secretion
Brand: www.djecji-vrtic-kucica.hr
SKU: 78791854346
Price: 23.93 USD
Availability: InStock
Rating: 4.2808 (18 reviews)

FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice PMC Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Deficiency of GDF 11 Accelerates TAC Induced Heart Failure by Impairing Cardiac Angiogenesis JACC: Basic to Translational Science

SKU: 78791854346 · From www.djecji-vrtic-kucica.hr

4.3

USD23.93 USD63.93

Pay in 4 interest-free payments of $5.98 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

Description

Endocrine: modulation of cortisol, GH, and LH secretion

Long-acting, the formula has been proven to increase the peaks and valleys of GH secretion and IGF-I production

References and Storage Sources Peptide stability guidance is consistent on the main principle: dry peptide powder is more stable than peptide solution, and reconstituted peptides require shorter, colder, cleaner handling